What’s New in PAH in 2024
Dr. Melissa Wilson discusses new treatments in the field of pulmonary hypertension in 2024, focusing on Sotatercept and combination therapy with Opsynvi. Dr. Wilson emphasizes the importance of patient selection and individualized treatment plans. She also discusses the initiation and monitoring of these therapies, as well as potential side effects and patient adherence.
Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA.
Is this SOB my problem or yours? : Referral to Cardiology
Imposter Syndrome: Who me?
Understanding MAC
Biologics in COPD: Why, when, and who
Inhaler 101
APAPP Board Member Tyler Kuhk an adult gerontology nurse practitioner, discusses the complexities of inhalers and the various types of inhaler devices used in respiratory care. Stream our latest podcast episode on Apple Podcasts, Spotify, and YouTube.
ECMO: Who is the right patient?
Dr. Susan Wilcox, medical director of the medical ICU at Leahy Hospital, delves into ECMO (Extracorporeal Membrane Oxygenation) and its applications, emphasizing its critical role in supporting the lungs.